NRXP

Nrx Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth↓ 2/10
  • Momentum↓ 2/10
Nrx Pharmaceuticals sales and earnings growth
NRXP Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -10.28%
  • FCF Y/Y↓ -6.54%
Nrx Pharmaceuticals gross and profit margin trends
NRXP Profitability
Good
  • Gross margin ↑ 59.90%
  • EPS margin↓ -15727.70%
  • ROIC↑ 172.10%
Nrx Pharmaceuticals net debt vs free cash flow
NRXP Risk
Great
  • Debt / Equity↓ -0.4
  • Debt / FCF↓ 0.3
  • Interest coverage↓ NA

Nrx Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗